This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Medidata Solutions Announces Enhanced Capabilities And Stand-Alone Option For Medidata Balance

Medidata Solutions (NASDAQ: MDSO), a leading global provider of cloud-based clinical development solutions, announced that Medidata Balance , the intelligent randomization and trial supply solution, is now being offered as a stand-alone system. This is a new alternative to the Balance solution that is unified with Medidata Rave ®, the industry-leading electronic data capture (EDC), management and reporting system.

With powerful enhancements, including new trial supply capabilities and additional ways to conduct randomized trials, Balance introduces a new level of agility in randomization and supply management, whether used with or without Medidata Rave for electronic data collection.

As always, with Medidata Balance the need for software programming and extensive testing is eliminated. Balance brings together all elements of the design and execution of randomization and supply logistics plans into one simple solution operating out of the Medidata Clinical Cloud. The new version includes:

  • A straightforward web interface guiding the creation of the randomization design and supply plans, including definition of complex dosing rules,
  • A powerful dynamic allocation algorithm or permuted block method, now offering integrated list generation, that creates the assignments to arms and strata, and
  • A groundbreaking integrated simulation tool testing the allocation of subjects and confirming the desired level of balance.

The new stand-alone version uses the same clean interface to deliver randomization and supply logistical information to study site staff. Additionally, the cloud-based solution offers site users a simple, intuitive web interface for screening, enrollment, randomization and kit dispensation.

“We continue to enhance the power and versatility of Medidata Balance to enable our customers to be more agile – to quickly adapt to changing needs and priorities, manage increased trial complexity and realize new efficiencies,” said Glen de Vries, president, Medidata Solutions. “With the introduction of this new version of Balance, customers can create and execute trial randomization and supply plans within the pre-validated solution and without being restricted by EDC compatibility.”

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,912.11 -70.48 -0.42%
S&P 500 1,969.95 -8.96 -0.45%
NASDAQ 4,442.6980 -2.2110 -0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs